Paper Details
- Home
- Paper Details
Systemic retinoids for chemoprevention of non-melanoma skin cancer in high-risk patients.
Author: BairSarah M, CherpelisBasil S, GlassL Frank, MarquezChristina, SmithbergerErica
Original Abstract of the Article :
Patients at high risk for the development of multiple non-melanoma skin cancers, especially those receiving immunosuppressive medications following solid organ transplantation, are candidates for chemoprophylaxis. In patients where photo-protection and topical medications are insufficient to prevent...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/20677528
データ提供:米国国立医学図書館(NLM)
Retinoids for Skin Cancer Prevention: A Promising Strategy
The study explores the potential of systemic retinoids for the chemoprevention of non-melanoma skin cancer (NMSC) in high-risk patients. The authors examine the growing body of evidence supporting the use of oral retinoids, including vitamin A and synthetic derivatives like isotretinoin, etretinate, and acitretin, in preventing NMSC in individuals with a heightened risk, particularly those receiving immunosuppressive medications after organ transplantation. This comprehensive review delves into the mechanisms of action of retinoids and provides a detailed analysis of their efficacy in preventing NMSC. Notably, the study also presents anecdotal evidence suggesting that bexarotene, a rexinoid, may offer comparable chemopreventive benefits to acitretin, with similar side effects at recommended doses.
Retinoids: A Shield Against Skin Cancer in High-Risk Individuals
The study's findings suggest that retinoids, particularly oral retinoids, hold significant promise as chemopreventive agents for NMSC in high-risk individuals. The evidence presented, combined with the anecdotal support for bexarotene, suggests that these agents may effectively reduce the incidence of NMSC in individuals susceptible to this type of cancer. However, it is crucial to carefully evaluate the individual risks and benefits of retinoid therapy, as they can have potential side effects, and to consult with a healthcare professional for personalized guidance.
Protecting Your Skin: A Multifaceted Approach
The study emphasizes the importance of adopting a comprehensive approach to skin cancer prevention, including photoprotection measures like wearing sunscreen and protective clothing, as well as topical medications. In cases where these measures prove insufficient, oral retinoids may offer a valuable adjunct to reduce the risk of developing NMSC. Remember, sun exposure is a major risk factor for skin cancer, so it is crucial to protect your skin from the sun's harmful rays, especially during peak hours. By taking these preventative measures, you can significantly reduce your risk of developing skin cancer.
Dr.Camel's Conclusion
This study provides valuable insights into the potential of retinoids for preventing skin cancer, particularly in high-risk individuals. It is crucial to remember that prevention is key, and by adopting a multi-pronged approach that includes sun protection, topical medications, and, when necessary, oral retinoids, we can effectively combat this prevalent disease. As a desert camel, I know the importance of protecting oneself from the sun's harsh rays. Let's all embrace the power of prevention and keep our skin healthy and safe from the dangers of skin cancer.
Date :
- Date Completed 2010-08-24
- Date Revised 2018-12-01
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.